Detalhe da pesquisa
1.
Nutritional Status and Incidence of Radiation-Induced Oral Mucositis in Nasopharyngeal Carcinoma Patients Treated with Chemoradiotherapy.
Nutr Cancer
; 76(2): 196-206, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38113055
2.
Serum and urine metabolomics analyses reveal metabolic pathways and biomarkers in relation to nasopharyngeal carcinoma.
Rapid Commun Mass Spectrom
; 37(6): e9469, 2023 Mar 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-36593223
3.
Plasma Epstein-Barr Virus MicroRNA BART8-3p as a Diagnostic and Prognostic Biomarker in Nasopharyngeal Carcinoma.
Oncologist
; 27(4): e340-e349, 2022 04 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35380720
4.
Prognostic value of SEC61G in lung adenocarcinoma: a comprehensive study based on bioinformatics and in vitro validation.
BMC Cancer
; 21(1): 1216, 2021 Nov 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-34774014
5.
Circulating Epstein-Barr virus microRNAs BART7-3p and BART13-3p as novel biomarkers in nasopharyngeal carcinoma.
Cancer Sci
; 111(5): 1711-1723, 2020 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-32155300
6.
Pretreatment Serum Lactate Dehydrogenase Level as an Independent Prognostic Factor of Nasopharyngeal Carcinoma in the Intensity-Modulated Radiation Therapy Era.
Med Sci Monit
; 23: 437-445, 2017 Jan 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-28120819
7.
Long-term survival of nasopharyngeal carcinoma patients with Stage II in intensity-modulated radiation therapy era.
Jpn J Clin Oncol
; 46(3): 241-7, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26755831
8.
Selectively sparing of the supraclavicular area during intensity-modulated radiotherapy in nasopharyngeal carcinoma: A double-center observation study.
Radiother Oncol
; 192: 110086, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38184146
9.
Budding uninhibited by benzimidazoles 1 overexpression is associated with poor prognosis and malignant phenotype: A promising therapeutic target for lung adenocarcinoma.
Thorac Cancer
; 14(10): 893-912, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36825773
10.
Impaired geriatric 8 score is associated with worse survival after radical intensity modulated radiation therapy in elderly patients with nasopharyngeal carcinoma.
Acta Otolaryngol
; 143(4): 334-339, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-36994877
11.
Lack of association between XRCC1 SNPs and acute radiationinduced injury or prognosis in patients with nasopharyngeal carcinoma.
Oncol Lett
; 26(6): 544, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-38020297
12.
Identification of immune-related genes contributing to head and neck squamous cell carcinoma development using weighted gene co-expression network analysis.
Cancer Rep (Hoboken)
; 6(5): e1808, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37092360
13.
Prioritizing sufficient dose to gross tumor volume over normal tissue sparing in intensity-modulated radiotherapy treatment of T4 nasopharyngeal carcinoma.
Head Neck
; 45(5): 1130-1140, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36856128
14.
A Novel Prognostic Model Predicts Outcomes in Non-Metastatic Nasopharyngeal Carcinoma Based on Inflammation, Nutrition, and Coagulation Signature.
J Inflamm Res
; 16: 5515-5529, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38026257
15.
Constructing an individualized surveillance framework for nasopharyngeal carcinoma based on a dynamic risk-adapted approach.
Radiother Oncol
; 185: 109716, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37207875
16.
The role of radiologic extranodal extension in predicting prognosis and chemotherapy benefit for T1-2 N1 nasopharyngeal carcinoma: A multicenter retrospective study.
Radiother Oncol
; 178: 109436, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36464180
17.
Anatomic prognostic factors and their potential roles in refining M1 classification for de novo metastatic nasopharyngeal carcinoma.
Cancer Med
; 12(24): 22091-22102, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38073447
18.
MRI-based deep learning model predicts distant metastasis and chemotherapy benefit in stage II nasopharyngeal carcinoma.
iScience
; 26(6): 106932, 2023 Jun 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-37378335
19.
Clinical Efficacy of Osimertinib in Patients with Advanced Non-Small Cell Lung Cancer and Its Effect on Serum CEA and VEGF Expression.
Evid Based Complement Alternat Med
; 2022: 3032087, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35664943
20.
High Expression of CKS2 Predicts Adverse Outcomes: A Potential Therapeutic Target for Glioma.
Front Immunol
; 13: 881453, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35663965